Intrauterine growth retardation (IUGR) has been linked to later development of type 2 diabetes in adulthood. Emerging data suggest that epigenetics may be an underlying mechanism. Decreased Pdx1 expression, a key regulator of ss-cell growth and function, plays a pivotal role in the development of diabetes in humans as well as in IUGR animals. One of the earliest molecular events involved in silencing the Pdx1 promoter in fetal pancreas of IUGR animals is the loss of USF1 binding. This is coincident with histone deacetylation, which suggests that in the absence of USF1, chromatin reverts to a heterochromatin conformation leading to transcriptional silencing. We suggest that USF1 binding establishes an active chromatin domain by recruiting histone modifying enzymes which maintain high levels of histone acetylation and methylation at Pdx1 as well as at other genes regulated by USF1 in the ss-cell. In previous studies we identified extensive genomic DNA hypermethylation and hypomethylation in IUGR islets. These alterations in DNA methylation were in highly conserved intergenic sequences and were associated with significant changes in expression of adjacent genes, suggesting that these may represent cis-regulatory sites (distal enhancers). Taken together, these studies and our data suggest DNA methylation and histone modifications interact at intergenic loci to regulate gene expression.
Specific Aim 1 : To test the hypotheses that USF1 recruits histone-modifying enzymes that maintain H3 acetylation and H3K4 methylation, and that loss of USF1 binding initiates chromatin remodeling in ss-cells.
Specific Aim 2 : To test the hypothesis that changes in DNA methylation in combination with histone modifications at intergenic loci (distal enhancers) alter gene expression in IUGR islets.
Specific Aim 3 : To test the hypothesis that the mechanism by which gene expression is increased in IUGR islets occurs through the induction of histone modifications, which in turn drive the loss of DNA methylation.

Public Health Relevance

The studies outlined in this proposal will be the first to directly link epigenetic modifications to a disease state. Determining the mechanisms underlying aberrant DNA methylation and histone modifications will further our understanding of this complex process and will enable us to develop new therapeutic agents to treat diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK055704-11
Application #
8469025
Study Section
Pregnancy and Neonatology Study Section (PN)
Program Officer
Appel, Michael C
Project Start
2000-06-01
Project End
2015-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
11
Fiscal Year
2013
Total Cost
$302,237
Indirect Cost
$113,339
Name
University of Pennsylvania
Department
Pediatrics
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Jaeckle Santos, Lane J; Li, Changhong; Doulias, Paschalis-Thomas et al. (2014) Neutralizing Th2 inflammation in neonatal islets prevents ?-cell failure in adult IUGR rats. Diabetes 63:1672-84
Pinney, S E; Jaeckle Santos, L J; Han, Y et al. (2011) Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat. Diabetologia 54:2606-14
Stefan, Mihaela; Simmons, Rebecca A; Bertera, Suzanne et al. (2011) Global deficits in development, function, and gene expression in the endocrine pancreas in a deletion mouse model of Prader-Willi syndrome. Am J Physiol Endocrinol Metab 300:E909-22
Simmons, Rebecca (2011) Epigenetics and maternal nutrition: nature v. nurture. Proc Nutr Soc 70:73-81
Wang, Xiaodan; Vatamaniuk, Marko Z; Roneker, Carol A et al. (2011) Knockouts of SOD1 and GPX1 exert different impacts on murine islet function and pancreatic integrity. Antioxid Redox Signal 14:391-401
Pinney, Sara E; Simmons, Rebecca A (2010) Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab 21:223-9
Brown, Suzanne B; Libonati, Joseph R; Selak, Mary A et al. (2010) Neonatal exendin-4 leads to protection from reperfusion injury and reduced rates of oxidative phosphorylation in the adult rat heart. Cardiovasc Drugs Ther 24:197-205
Thompson, Reid F; Fazzari, Melissa J; Niu, Hongshun et al. (2010) Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 285:15111-8
Sen, Sarbattama; Simmons, Rebecca A (2010) Maternal antioxidant supplementation prevents adiposity in the offspring of Western diet-fed rats. Diabetes 59:3058-65
Raab, Elisabeth L; Vuguin, Patricia M; Stoffers, Doris A et al. (2009) Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats. Am J Physiol Regul Integr Comp Physiol 297:R1785-94

Showing the most recent 10 out of 23 publications